Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Will the addition of 24-chromosome microarray analysis on miscarriage tissue combined with the standard American Society for Reproductive Medicine (ASRM) evaluation for recurrent miscarriage explain most losses? SUMMARY ANSWER: Over 90% of patients with recurrent pregnancy loss (RPL) will have a probable or definitive cause identified when combining genetic testing on miscarriage tissue with the standard ASRM evaluation for recurrent miscarriage. WHAT IS KNOWN ALREADY: RPL is estimated to occur in 2-4% of reproductive age couples. A probable cause can be identified in approximately 50% of patients after an ASRM recommended workup including an evaluation for parental chromosomal abnormalities, congenital and acquired uterine anomalies, endocrine imbalances and autoimmune factors including antiphospholipid syndrome. STUDY DESIGN, SIZE, DURATION: Single-center, prospective cohort study that included 100 patients seen in a private RPL clinic from 2014 to 2017. All 100 women had two or more pregnancy losses, a complete evaluation for RPL as defined by the ASRM, and miscarriage tissue evaluated by 24-chromosome microarray analysis after their second or subsequent miscarriage. PARTICIPANTS/MATERIALS, SETTING, METHODS: Frequencies of abnormal results for evidence-based diagnostic tests considered definite or probable causes of RPL (karyotyping for parental chromosomal abnormalities, and 24-chromosome microarray evaluation for products of conception (POC); pelvic sonohysterography, hysterosalpingogram, or hysteroscopy for uterine anomalies; immunological tests for lupus anticoagulant and anticardiolipin antibodies; and blood tests for thyroid stimulating hormone (TSH), prolactin and hemoglobin A1c) were evaluated. We excluded cases where there was maternal cell contamination of the miscarriage tissue or if the ASRM evaluation was incomplete. A cost analysis for the evaluation of RPL was conducted to determine whether a proposed procedure of 24-chromome microarray evaluation followed by an ASRM RPL workup (for those RPL patients who had a normal 24-chromosome microarray evaluation) was more cost-efficient than conducting ASRM RPL workups on RPL patients followed by 24-chromosome microarray analysis (for those RPL patients who had a normal RPL workup). MAIN RESULTS AND THE ROLE OF CHANCE: A definite or probable cause of pregnancy loss was identified in the vast majority (95/100; 95%) of RPL patients when a 24-chromosome pair microarray evaluation of POC testing is combined with the standard ASRM RPL workup evaluation at the time of the second or subsequent loss. The ASRM RPL workup identified an abnormality and a probable explanation for pregnancy loss in only 45/100 or 45% of all patients. A definite abnormality was identified in 67/100 patients or 67% when initial testing was performed using 24-chromosome microarray analyses on the miscarriage tissue. Only 5/100 (5%) patients, who had a euploid loss and a normal ASRM RPL workup, had a pregnancy loss without a probable or definitive cause identified. All other losses were explained by an abnormal 24-chromosome microarray analysis of the miscarriage tissue, an abnormal finding of the RPL workup, or a combination of both. Results from the cost analysis indicated that an initial approach of using a 24-chromosome microarray analysis on miscarriage tissue resulted in a 50% savings in cost to the health care system and to the patient. LIMITATIONS, REASONS FOR CAUTION: This is a single-center study on a small group of well-characterized women with RPL. There was an incomplete follow-up on subsequent pregnancy outcomes after evaluation, however this should not affect our principal results. The maternal age of patients varied from 26 to 45 years old. More aneuploid pregnancy losses would be expected in older women, particularly over the age of 35 years old. WIDER IMPLICATIONS OF THE FINDINGS: Evaluation of POC using 24-chromosome microarray analysis adds significantly to the ASRM recommended evaluation of RPL. Genetic evaluation on miscarriage tissue obtained at the time of the second and subsequent pregnancy losses should be offered to all couples with two or more consecutive pregnancy losses. The combination of a genetic evaluation on miscarriage tissue with an evidence-based evaluation for RPL will identify a probable or definitive cause in over 90% of miscarriages. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for this study and there are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: Not applicable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other than the prognostic advantages, when used in combination with routine investigations into recurrent miscarriage, cytogenetic analysis of the pregnancy tissue have shown to provide a diagnosis in over 90% of couples.137”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [137]
Citations
Cites
1 retracted
RETIRED: Technical Update: Preimplantation Genetic Diagnosis and Screening
Dahdouh, E. M., Balayla, J., Audibert, F., Wilson, R. D., Audibert, F., Brock, J., Campagnolo, C., Carroll, J. C., Chong, K., Gagnon, A. L., et al. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30261-9 · Cited by 107
RetractedChromosomal microarray versus karyotyping for prenatal diagnosis
Wapner, R. J., Martin, C. L., Levy, B., Ballif, B. C., Eng, C. M., Zachary, J. M., Savage, M., Platt, L. D., Saltzman, D., Grobman, W. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203382 · Cited by 1,412 · cited 1×
“Previous investigators have demonstrated that the detection of genetic abnormalities in miscarriage tissue is significantly improved by CMA analysis compared to standard karyotype (Reddy et al., 2012; Wapner et al., 2012; Lo et al., 2014).”
BackgroundEvaluation and treatment of recurrent pregnancy loss: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.048 · Cited by 1,308
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
A cytogenetic study of 1000 spontaneous abortions
HASSOLD, T., CHEN, N., FUNKHOUSER, J., JOOSS, T., MANUEL, B., MATSUURA, J., MATSUYAMA, A., WILSON, C., Yamane, J. A., & JACOBS, P. A. (1980) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1980.tb00955.x · Cited by 676
Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions
Boué, J., Boué, A., & Lazar, P. (1975) · Teratology · doi:10.1002/tera.1420120103 · Cited by 661
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Jauniaux, E. (2006) · Human Reproduction · doi:10.1093/humrep/del150 · Cited by 520 · cited 2×
“Although the presence of a particular abnormal test result does not prove that it caused the pregnancy losses in these patients, abnormalities in parental genetics, uterine anatomy, lupus anticoagulant, anticardiolipin antibodies, TSH and hemoglobin A1c are considered either probable or definite causes of RPL (Christi…”
BackgroundStray-Pedersen, B., & Stray-Pedersen, S. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)80164-7 · Cited by 483
Human aneuploidy: Incidence, origin, and etiology
Hassold, T., Abruzzo, M., Adkins, K., Griffin, D., Merrill, M., Millie, E., Saker, D., Shen, J., & Zaragoza, M. (1996) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1996)28:3<167::aid-em2>3.0.co;2-b · Cited by 456
Frequency of factors associated with habitual abortion in 197 couples
Daya, S., & Stephenson, M. D. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58382-4 · Cited by 428
Research works printed but not linked: 2
- Brezina, 2013, Clinical Reproductive Medicine and Surgery: A Practical Guide, 1
- Moraes, 2005, Cytogenetic and molecular evaluation of spontaneous abortion samples, Rev Bras Ginecol Obstet, 27, 554
Cited by
Items 101–147 of 147
Abdallah, A. (2025) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2025.32.1.0266 · Cited by 4
Pasquier, É., Martin, L. D. S., Marhic, G., Gal, G. L., Delluc, A., Pimentel, C., MEKINIAN, A., Chauleur, C., Plu‐Bureau, G., Bohec, C., et al. (2026) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/s3050-5038(25)00207-9 · Cited by 2
Time to reduce the rate of idiopathic recurrent pregnancy losses
Tutchenko, T. М., Бурка, О. А., Samilyk, V. S., Trokhymovych, О. V., Krotik, O. І., & Громова, О. Л. (2020) · Reproductive Endocrinology · doi:10.18370/2309-4117.2020.55.21-28 · Cited by 2
van Zutven, L. J. C. M., Mijalkovic, J., van Veghel–Plandsoen, M. M., Goense, M., POLAK, M. G., Knapen, M. F. C. M., de Weerd, S., Joosten, M., Diderich, K. E. M., Hoefsloot, L. H., et al. (2023) · Molecular Cytogenetics · doi:10.1186/s13039-023-00657-x · Cited by 2
“Moreover, it will help to diagnose the etiology of pregnancy loss in more cases [25].”
BackgroundKocaağa, A., & Salık, E. A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10557-5 · Cited by 2
Zhou, Y., Xu, W., Jiang, Y., Xia, Z., Zhang, H., Chen, X., Wang, Z., Ge, Y., & Guo, Q. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.01.005 · Cited by 2
Kutteh, W. H., Papas, R. S., & Dahdouh, E. M. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.10.008 · Cited by 2
Self-citationBhasker, N. (2022) · Biochemistry · doi:10.5772/intechopen.100125 · Cited by 2
Morphogenesis of decidual transformation of the endometrium. A literature review
Tral, T. G., Kruglova, D. D., & Tolibova, G. K. (2023) · Journal of obstetrics and women s diseases · doi:10.17816/jowd531483 · Cited by 1
Frühschwangerschaft: klinische Aspekte und Abortgeschehen
von Steinburg, S. P. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-63506-3_2 · Cited by 1
Exploring the complexities of recurrent spontaneous abortion: An overview of contributing factors
Abdallah, A. (2025) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2025.25.2.0520 · Cited by 4
“RPL is estimated to occur in 2% – 4% of reproductive-age couples [7,8].”
Honda, H., Takiuchi, T., Handa, M., Wakui, N., Tsuji, S., Goto, T. K., Suzuki, S., Saji, F., Miyake, T., Goto, S., et al. (2025) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12655 · Cited by 1
“Popescu et al. 8 reported that the majority of women with a history of two pregnancy losses who underwent POC chromosomal microarray analysis that was abnormal had a normal result on RPL-related testing recommended by the American Society for Reproductive Medicine (74.6%).”
InfluentialResearch overview and hotspots in the field of recurrent miscarriage: A literature-mining study
Shen, C., Zhang, J., Zhang, M., Yuan, Q., Lu, Y., Miao, L., & Wang, W. L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1605088 · Cited by 1
Genetic testing aids diagnosis in post mid-trimester pregnancy termination of anomalous fetuses
Rakholia, V. D., Yan, C. W., Lim, J. Y., Kam, S., Goh, J. C., Teck, T. T. Y., Choy, K. W., & Jamuar, S. S. (2026) · Rare · doi:10.1016/j.rare.2026.100126 · Cited by 1
Therapeutisches Vorgehen bei verhaltenem Abort – Plädoyer für ein risikoarmes Vorgehen
Popovici, R. (2018) · Gynäkologische Endokrinologie · doi:10.1007/s10304-018-0199-6 · Cited by 1
Recurrent Pregnancy Loss: Investigations and Interventions
Lopes, V. M., Souza-Oliveira, M. C., Goulart, A. E. C., Pimentel, E. S., Tierno, N. I. Z., Ribeiro, T. Q. F., Medina, C. T., Castro, V. L., Lima, L. G. N., Souza, A. L. M., et al. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89590 · Cited by 1
Kojok, D., Ghazeeri, G. S., & Kutteh, W. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89907-9.00026-0 · Cited by 1
Self-citationTanabe, A., Banno, C., Otani, T., Yoshihara, H., Goto, S., Kitaori, T., & Sugiura‐Ogasawara, M. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104335 · Cited by 1
Honda, H., Handa, M., Takiuchi, T., Tsuji, S., Goto, T. K., Miyake, T., & Kimura, T. (2024) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096241304530 · Cited by 1
Delhanty, J. D. A. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0021444.pub2 · Cited by 1
Recurrent Pregnancy Loss in the First and Second Trimesters
Tarlatzis, B. C., Sotiriadis, A., & Grimbizis, G. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108582322.014
Jackson, T. (2022) · Physician Assistant Clinics · doi:10.1016/j.cpha.2022.03.004
Recurrent Pregnancy Loss: reviewing therapeutic approaches
de Oliveira, E. C. F., Praça, M. S. L., Garcia, G. M. P., & Cavallo, I. K. D. (2022) · Human Reproduction Archives · doi:10.4322/hra.000721
“Patients who underwent intrauterine insemination (IUI), IVF and pre-implantation genetic screening (PGS) conceived at a mean time of 3 (1-9), 4 (1-12) and 5 (2-10) months, respectively.”
BackgroundMethodHanif, M. I., Mansoor, Q., Arif, A., Shoeb, E., Ismail, M., Khan, A. H., & Ajaz, S. (2023) · Liaquat National Journal of Primary Care · doi:10.37184/lnjpc.2707-3521.5.21 · Cited by 1
Chromosomal Microarray on Product of Conception in Early Pregnancy Loss: A Case Report
Mallakmir, S., Mulgund, G., & Merchant, R. H. (2023) · Apollo Medicine · doi:10.4103/am.am_70_23
“[1] The major percentage of early RPL (50%–60”
Trolice, M. P. (2023) · OBG Management · doi:10.12788/obgm.0285
Frühschwangerschaft: klinische Aspekte und Abortgeschehen
von Steinburg, S. P. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-44369-9_2-2
Amrani, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65371-5_7
Li, S., Chen, M., & Zheng, P. (2021) · Research Square · doi:10.21203/rs.3.rs-451906/v1
Update on Diagnosis and Management of Recurrent Early Pregnancy Loss
Vessa, B., Kalakota, N. R., Loughlin, J. S., & Morelli, S. S. (2024) · Topics in Obstetrics & Gynecology · doi:10.1097/01.pgo.0001050372.18319.bd
Investigation of Recurrent Pregnancy Loss
Al-Lamee, H., & Elson, J. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.016
Pregnancy Loss: From Cytogenetics to Genomics
Tise, C. G., Verma, K., & Lathi, R. B. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.029
Guidelines on the Diagnosis and Management of Sporadic Miscarriage
Oliver, A., & Overton, C. E. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.015
Dynamic Prediction Models for Recurrent Pregnancy Loss
van der Hoorn, M.-L., Goddijn, M., & Lashley, E. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.028
The Uncertain Science of Preimplantation Genetic Testing for Reproduction
Sugiura-Ogasawara, M., Sato, T., Goto, S., & Yoshihara, H. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.008
Early Placental Development and Disorders
Pennington, K. A., Kilgore-Nolan, Q., Shay, L., & Schust, D. J. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.007
Study of abortion material in idiopathic habitual miscarriage of pregnancy: Literature review
Sadyrbekova, A., Svyatova, G., Berezina, G., Suleimenova, R. K., & Murtazaliyeva, A. (2025) · Polski Merkuriusz Lekarski · doi:10.36740/merkur202503117
Chromosome Abnormality Detection Rates of QF-PCR in Early Pregnancy Loss.
Popescu‐Hobeanu, G., Cucu, M., Riza, A., Streață, I., Pleşea, R. M., Dorobantu, S., Barbu, A., Zorilă, G. L., Dinu, M., Dijmărescu, A. L., et al. (2025) · PubMed Central · doi:10.12865/chsj.51.01.06
“The reported MCC rate ranges between 10.5 and 22% [53,78,79], but can go as high as 89.7% [80] in some cases, depending on sample inclusion criteria and the type of procedure used to obtain POC specimens [81].”
InfluentialEndometrial and placental dysfunction in recurrent pregnancy loss
Hamid, L., Mir, S. A., Nisar, N., Dar, L. A., Khan, N. A., Tak, H., & Bader, G. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13617-7.00012-8
Unveiling recurrent pregnancy loss: Insights from molecular techniques
Dar, Z. A., Banerjee, A. K., Panpatil, V., Katragadda, A., Ramesh, P., Farooq, N., Afreen, N., Ghosh, S., & Rao, D. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13617-7.00004-9
Is embryo ploidy sufficient to explain transfer success in recurrent pregnancy loss?
George, L., & Franasiak, J. M. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.01.022
Miscarriages: Epidemiology, diagnosis, and management
MEKINIAN, A., & Abisror, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00357-5
Tu, J., Wangchen, M., Liu, J., Zhou, J., & Gong, F. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-08929-1
“A study by Popescu et al. demonstrated that 84.8% of euploid miscarriages were associated with positive findings of maternal factors, compared to only 25.4% in aneuploid losses [10].”
InfluentialYu, L., Tang, Y., Kong, N., Liu, J., He, F., Zhang, N., & Mei, J. (2026) · BioMed Research International · doi:10.1155/bmri/8875136
“When POC analysis is performed, de novo aneuploidy is identified as a primary etiology in 40%–50% of early pregnancy losses [8, 9].”
Duka, Y. M., Panov, V. V., & Plyg, O. O. (2026) · UKRAINIAN JOURNAL HEALTH OF WOMAN · doi:10.15574/hw.2026.1(182).91105
Dahdouh, E. M., Sylvestre, C. V., Balayla, J., Sharara, F. I., & Kutteh, W. H. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103419
Self-citationEarly Pregnancy and Miscarriage
von Steinburg, S. P. (2026) · Springer eBooks · doi:10.1007/978-3-662-70578-0_2
Metadata
- Authors
- Popescu, F., Jaslow, C. R., & Kutteh, W. H.
- Affiliations
- Rhodes College (US)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Kutteh, W H
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-12
- Volume
- 33
- Issue
- 4
- Pages
- 579-587
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2794293654
- Cited by
- 141
- References
- 46
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 17 · 2023: 28 · 2022: 19 · 2021: 20 · 2020: 18 · 2019: 10 · 2018: 7
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- recurrent pregnancy loss, miscarriage, uterine anomalies, antiphospholipid syndrome, lupus anticoagulant, anticardiolipin antibodies, thyroid function, prolactin, cost analysis, diagnostic yield, endometrial receptivity
- MeSH terms
- Abortion, Habitual, Adult, Chromosome Aberrations, Female, Genetic Testing, Humans, Karyotyping, Maternal Age, Middle Aged, Pregnancy, Pregnancy Outcome, Prospective Studies, Tissue Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.